04 feb: Nordic Surveillance Annual Report 2018
05 feb: Nykredit Realkredit-koncernen - Årsrapport 2018
04-02-2019 13:40:00

Market Trends Toward New Normal in Teva Pharmaceutical Industries, Air Lease, Brunswick, LogMein, Core-Mark Holding, and Vectrus — Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Air Lease Corporation (NYSE:AL), Brunswick Corporation (NYSE:BC), LogMein, Inc. (NASDAQ:LOGM), Core-Mark Holding Company, Inc. (NASDAQ:CORE), and Vectrus, Inc. (NYSE:VEC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TEVA DOWNLOAD: https://Fundamental-Markets.com/register/?so=TEVA

AL DOWNLOAD: https://Fundamental-Markets.com/register/?so=AL

BC DOWNLOAD: https://Fundamental-Markets.com/register/?so=BC

LOGM DOWNLOAD: https://Fundamental-Markets.com/register/?so=LOGM

CORE DOWNLOAD: https://Fundamental-Markets.com/register/?so=CORE

VEC DOWNLOAD: https://Fundamental-Markets.com/register/?so=VEC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Air Lease Corporation (NYSE:AL), Brunswick Corporation (NYSE:BC), LogMein, Inc. (NASDAQ:LOGM), Core-Mark Holding Company, Inc. (NASDAQ:CORE), and Vectrus, Inc. (NYSE:VEC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice:

the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 31st, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TEVA PHARMACEUTICAL INDUSTRIES LTD. (TEVA) REPORT OVERVIEW

Teva Pharmaceutical Industries' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Teva Pharmaceutical Industries reported revenue of $4,529.00MM vs $5,617.00MM (down 19.37%) and analysts estimated basic earnings per share -$0.27 vs $0.52. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Teva Pharmaceutical Industries reported revenue of $22,385.00MM vs $21,903.00MM (up 2.20%) and analysts estimated basic earnings per share -$16.26 vs $0.07. Analysts expect earnings to be released on February 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.91. The estimated EPS forecast for the next fiscal year is $2.66 and is expected to report on February 13th, 2019.

To read the full Teva Pharmaceutical Industries Ltd. (TEVA) report, download it here: https://Fundamental-Markets.com/register/?so=TEVA

-----------------------------------------

AIR LEASE CORPORATION (AL) REPORT OVERVIEW

Air Lease's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Air Lease reported revenue of $450.70MM vs $376.77MM (up 19.62%) and analysts estimated basic earnings per share $1.41 vs $0.96 (up 46.88%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Air Lease reported revenue of $1,516.38MM vs $1,419.06MM (up 6.86%) and analysts estimated basic earnings per share $7.33 vs $3.65 (up 100.82%). Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.06. The estimated EPS forecast for the next fiscal year is $5.55 and is expected to report on February 21st, 2019.

To read the full Air Lease Corporation (AL) report, download it here: https://Fundamental-Markets.com/register/?so=AL

-----------------------------------------

BRUNSWICK CORPORATION (BC) REPORT OVERVIEW

Brunswick's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Brunswick reported revenue of $1,298.00MM vs $1,141.50MM (up 13.71%) and analysts estimated basic earnings per share $0.80 vs $0.89 (down 10.11%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Brunswick reported revenue of $4,510.00MM vs $4,153.90MM (up 8.57%) and analysts estimated basic earnings per share $1.64 vs $3.03 (down 45.87%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $1.01. The estimated EPS forecast for the next fiscal year is $5.97 and is expected to report on January 30th, 2020.

To read the full Brunswick Corporation (BC) report, download it here: https://Fundamental-Markets.com/register/?so=BC

-----------------------------------------

LOGMEIN, INC. (LOGM) REPORT OVERVIEW

LogMein's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, LogMein reported revenue of $308.93MM vs $269.27MM (up 14.73%) and basic earnings per share $0.25 vs $0.19 (up 31.58%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, LogMein reported revenue of $989.79MM vs $336.07MM (up 194.52%) and analysts estimated basic earnings per share $1.97 vs $0.10 (up 1,870.00%). Analysts expect earnings to be released on February 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.97. The estimated EPS forecast for the next fiscal year is $4.65 and is expected to report on February 14th, 2019.

To read the full LogMein, Inc. (LOGM) report, download it here: https://Fundamental-Markets.com/register/?so=LOGM

-----------------------------------------

CORE-MARK HOLDING COMPANY, INC. (CORE) REPORT OVERVIEW

Core-Mark Holding's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Core-Mark Holding reported revenue of $4,273.20MM vs $4,310.70MM (down 0.87%) and analysts estimated basic earnings per share $0.52 vs $0.29 (up 79.31%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Core-Mark Holding reported revenue of $15,687.60MM vs $14,529.40MM (up 7.97%) and analysts estimated basic earnings per share $0.72 vs $1.17 (down 38.46%). Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.33. The estimated EPS forecast for the next fiscal year is $1.48 and is expected to report on March 7th, 2019.

To read the full Core-Mark Holding Company, Inc. (CORE) report, download it here: https://Fundamental-Markets.com/register/?so=CORE

-----------------------------------------

VECTRUS, INC. (VEC) REPORT OVERVIEW

Vectrus' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Vectrus reported revenue of $308.10MM vs $269.63MM (up 14.27%) and analysts estimated basic earnings per share $0.88 vs $0.52 (up 69.23%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Vectrus reported revenue of $1,114.79MM vs $1,190.52MM (down 6.36%) and analysts estimated basic earnings per share $5.40 vs $2.21 (up 144.34%). Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.57. The estimated EPS forecast for the next fiscal year is $3.41 and is expected to report on March 7th, 2019.

To read the full Vectrus, Inc. (VEC) report, download it here: https://Fundamental-Markets.com/register/?so=VEC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:

Andrew Duffie, Media Department

Office: +1 667-401-0010

E-mail: media@Fundamental-Markets.com

© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Relateret indhold
Relateret debat
21 jul - 
Det bliver svært at bevise at det var medicinalfirmaern..
21 jul - 
Meget enig. Derudover kan nævnes at goodwill og immater..
21 jul - 
Lidt forenklet kan man sige, at de har købt et andet fi..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
20 jul
TEVA
Henningmaria: Casen omkring Teva har ikke ændret sig fundamentalt blot folks følelser pga verserende..
14
17 jul
TEVA
Har aldrig helt forstået de her “hvad sagde jeg”-tråde. Shortede du Teva da KS trådte til? Ellers vi..
9
20 jul
TEVA
der er som bekendt mange danskere som har tabt mange penge på Teva siden Kåre Schultz kom til som ad..
4
17 jul
TEVA
Når nu vi snart ser TEVA mellem kurs 6 og 4 USD er det min vurdering den er købsmoden. Så er der kun..
4
21 jul
TEVA
Lidt forenklet kan man sige, at de har købt et andet firma for penge de har lånt. Det er penge som s..
3
20 jul
TEVA
Jo, det er jo altsammen rigtigt, men indtjeningen skal jo ikke skuffe meget før de løber ind i probl..
3
21 jul
TEVA
Det bliver svært at bevise at det var medicinalfirmaernes skyld. Problem number one: In the practic..
2
17 jul
TEVA
hej tdt123 godt at høre fra dig, KS er gammel mckinsey mand det skal man aldrig undervurdere, det er..
2
17 jul
TEVA
Hehe tror nu ikke vi skal give KS skylden for karteldannelse og andre lig, de var ellers godt på vej..
2
21 jul
TEVA
Meget enig. Derudover kan nævnes at goodwill og immaterielle aktiver, som er det medicin firmaer har..
1

Fondsbørsmeddelelser

Euroinvestor spørger: Bliver Trump genvalgt i 2020 og har Amazon overhalet alle andre om ét år?

23-07-2019 20:23:36
Relaterede nyheder
Hos Euroinvestor mener vi, at den bedste kilde til viden om markedet er aktørerne i markedet. Derfor spørger vi hver måned i vores Privatinvestorundersøgelse (PIU) vores brugere om deres forventninger til markeder og økonomi. Du inviteres hermed til at deltage i undersøgelsen. Alle besvarelser er anonyme, og der er ingen krav om login, kontaktoplysninger eller lignende. Vi håber du vil deltage og ..

Genmab/Nordnet: Penge fra USA-notering ryger nok i udviklingsreserver

23-07-2019 12:25:21
Mandag gennemførte Genmab salget af flere millioner aktier i forbindelse med sin børsnotering i USA, og det indbragte selskabet frisk kapital, som formentlig vil blive lagt til side til fremtidige udviklingsprojekter.Sådan lyder vurderingen fra Per Hansen, investeringsøkonom hos børsmægleren Nordnet, om de godt 3,4 mia. kr., som Genmab har rejst i bruttoprovenu ved salget af 2,85 mio. nye aktier p..

Aktier/tendens: Udenlandsk udvikling bliver afgørende for DSV og andre

23-07-2019 08:22:55
Der er ikke meget fra det hjemlige at tage bestik af på det danske aktiemarked tirsdag morgen.Dermed bliver det den udenlandske udvikling, heriblandt et hæderligt regnskab fra DSV-kollegaen Kuehne+Nagel, der kommer til være bestemmende for retningen fra handlens start tirsdag.De ledende amerikanske aktieindeks sluttede mandag med plusser, og de asiatiske markeder har fulgt op på udviklingen med st..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Danmark/økonomer: Forbrugerne aner uråd
2
Veloxis/Kempen: Kursmålet løftes med 20 pct.
3
Aktier/tendens: Udenlandsk udvikling bliver afgørende for DSV og andre
4
Professor om Johnsons brexitplan: Han er kravlet op i et træ - NY
5
NKT får ordre på højspændingskabler til Viking Link - NY

Relaterede aktiekurser

Teva Pharmaceutical Indu.. 7,685 -0,1% Fald i aktiekurs
Brunswick Corporation 45,48 4,8% Stigning i aktiekurs
LogMein Inc 73,90 -1,1% Fald i aktiekurs
Core-Mark Holding Compan.. 37,87 0,6% Stigning i aktiekurs
Air Lease Corporation Cl.. 41,70 1,8% Stigning i aktiekurs
Vectrus Inc 41,63 1,3% Stigning i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. juli 2019 21:51:45
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190703.1 - EUROWEB4 - 2019-07-23 21:51:45 - 2019-07-23 21:51:45 - 1 - Website: OKAY